# Analgesic Effect of the QLB-3 for Patients Undergoing a Total Hip Surgery

> **NCT04555291** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 60 (actual)

## Conditions studied

- Total Hip Arthroplasty

## Interventions

- **DRUG:** Ropivacaine injection
- **OTHER:** NACL

## Key facts

- **NCT ID:** NCT04555291
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-05
- **Primary completion:** 2023-10-06
- **Final completion:** 2024-10-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04555291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04555291, "Analgesic Effect of the QLB-3 for Patients Undergoing a Total Hip Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04555291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*